New Insulin Manufacturer For Civica
Civica Enlists Swiss Ypsomed To Make Injector Pens
Ypsomed AG will manufacture insulin dosing injector pens for non-profit Civica. Civica has also paired up with AmerisourceBergen for generics supply chain support across the US.
You may also be interested in...
Pressure Builds For Biosimilars To Follow Lilly’s Lead After Insulin Price Cap
Biosimilar insulin producers are facing calls to improve patient affordability after Eli Lilly implemented a $35 price cap on copays for its insulins in the private market and for the uninsured.
Bipartisan Bills To Promote Drug Competition A Step Closer To Completion
The Preserving Access to Affordable Generics and Biosimilars Act and the Stop STALLING Act are both a step closer to becoming law after passing voice votes in the Senate Judiciary Committee.
Biocon Meets $650m Equity Infusion In Biocon Biologics To Fund Viatris Buy
Biocon Biologics is continuing to rack up the capital needed to close its multi-billion deal for Viatris’ global biosimilars business, with two quick equity investments from parent Biocon Limited as stipulated under its acquisition agreement.